LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹128 Cr | ₹138 Cr | ₹111 Cr | ₹93 Cr | ₹194 Cr |
What is the latest Revenue of LYKA LABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹128 Cr |
| Mar2025 | ₹138 Cr |
| Mar2024 | ₹111 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹194 Cr |
How is Revenue of LYKA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹128 Cr | -7.26 | |
| Mar2025 | ₹138 Cr | 24.55 | |
| Mar2024 | ₹111 Cr | 19.47 | |
| Mar2023 | ₹93 Cr | -52.05 | |
| Mar2022 | ₹194 Cr | - | |
Compare Revenue of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹298.5 Cr | -0.8% | 21.5% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.8% |
21.5% |
-18.3% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses